Disclosures
Dr. Roumeliotis reports no conflicts of interest.
Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare, IMDS, InfraRedx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health.
Interactive multiple choice questions are available for this chapter on www.wiley.com/go/dangas/cardiology
References
1 1 DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non‐Q‐wave myocardial infarction. The New England Journal of Medicine 1986; 315:417–23.
2 2 Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST‐Segment Elevation of the European Society of Cardiology (ESC). Eur Heart Jnl. 2016; 37:267–315.
3 3 Chew DP, Lambrakis K, Blyth A, et al. A Randomized Trial of a 1‐Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High‐Sensitivity Troponin T Study (RAPID‐TnT). Circulation 2019; 140:1543–56.
4 4 Frick, M. High‐sensitivity cardiac troponin at presentation to rule out myocardial infarction (HiSTORIC): a stepped‐wedge cluster‐randomised controlled trial. ESC Paris, France.2019.
5 5 Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ open 2014; 4:e004425.
6 6 Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835–42.
7 7 Amsterdam EA, Wenger NK. The 2014 American College of Cardiology ACC/American Heart Association guideline for the management of patients with non‐ST‐elevation acute coronary syndromes: ten contemporary recommendations to aid clinicians in optimizing patient outcomes. Clinical Cardiology 2015; 38:121–3.
8 8 Leonardi S, Armstrong PW, Schulte PJ, et al. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review. Eur Heart Jnl. 2013; 34:894‐902d.
9 9 O'Donoghue M, Boden WE, Braunwald E, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non‐ST‐segment elevation myocardial infarction: a meta‐analysis. JAMA 2008; 300:71–80.
10 10 Fox KA, Clayton TC, Damman P, et al. Long‐term outcome of a routine versus selective invasive strategy in patients with non‐ST‐segment elevation acute coronary syndrome a meta‐analysis of individual patient data. J Am Coll Cardiol 2010; 55:2435–45.
11 11 Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non‐ST‐elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open‐label randomised controlled trial. The Lancet (London, England) 2016; 387:1057–65.
12 12 Wallentin L, Lindhagen L, Arnstrom E, et al. Early invasive versus non‐invasive treatment in patients with non‐ST‐elevation acute coronary syndrome (FRISC‐II): 15 year follow‐up of a prospective, randomised, multicentre study. The Lancet (London, England) 2016; 388:1903–11.
13 13 Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non‐ST‐Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 64:e139–e228.
14 14 Neumann FJ, Sousa‐Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40:87–165.
15 15 Lopes RD, Leonardi S, Neely B, et al. Spontaneous MI After Non‐ST‐Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. J Am Coll Cardiol. 2016; 67:1289–97.
16 16 Jobs A, Mehta SR, Montalescot G, et al. Optimal timing of an invasive strategy in patients with non‐ST‐elevation acute coronary syndrome: a meta‐analysis of randomised trials. The Lancet (London, England) 2017; 390:737–46.
17 17 Kofoed KF, Kelbaek H, Hansen PR, et al. Early Versus Standard Care Invasive Examination and Treatment of Patients With Non‐ST‐Segment Elevation Acute Coronary Syndrome. Circulation 2018; 138:2741–50.
18 18 Valgimigli M, Gagnor A, Calabro P, et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. The Lancet 2015; 385:2465–76.
19 19 Holmes DR, Jr., Rich JB, Zoghbi WA, Mack MJ. The heart team of cardiovascular care. J Am Coll Cardiol. 2013; 61:903–7.
20 20 Ben‐Gal Y, Moses JW, Mehran R, et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovascular interventions 2010; 3:1059–67.
21 21 Freitas P, Madeira M, Raposo L, et al. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non‐ST‐Elevation Myocardial Infarction and Left Main or Multivessel Coronary Disease. The American Journal of Cardiology 2019; 123:717–24.
22 22 Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta‐analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62:1421–31.
23 23 Rathod KS, Koganti S, Jain AK, et al. Complete Versus Culprit‐Only Lesion Intervention in Patients With Acute Coronary Syndromes. J Am Coll Cardiol 2018; 72:1989–99.
24 24 Sardella G, Lucisano L, Garbo R, et al. Single‐Staged Compared With Multi‐Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J Am Coll Cardiol. 2016; 67:264–72.
25 25 Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007; 50:933–9.
26 26 Iannaccone M, D'Ascenzo F, Frangieh AH, et al. Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE‐CARDIOGROUP IV and USZ registry. Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography and Interventions 2017; 90:E46‐e52.
27 27 Meneveau N, Souteyrand G, Motreff P, et al. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non‐ST‐Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting). Circulation 2016; 134:906–17.
28 28 Stub D, Smith K, Bernard S, et al. Air Versus Oxygen in ST‐Segment‐Elevation Myocardial Infarction. Circulation 2015; 131:2143–50.
29 29 Hofmann R, James SK, Jernberg T, et al. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med.2017; 377:1240–9.
30 30 Borzak S, Cannon CP, Kraft PL, et al. Effects of prior aspirin and anti‐ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. J Am Coll Cardiol. 1998; 81:678–81.
31 31 Chatterjee S, Chaudhuri D, Vedanthan R, et al. Early intravenous beta‐blockers in patients with acute coronary syndrome‐‐a